Contact Us
Contact Us

Acute Pain Models

Lotus Supports Xgene’s Breakthrough Non-Opioid Pain Relief Clinical Trial

by

Lotus Supports Xgene’s Breakthrough Non-Opioid Pain Relief Trial We’re excited to share that Xgene Pharmaceutical has announced positive topline results from their late-phase trial of XG005, an innovative non-opioid treatment for post-surgical pain. Lotus Clinical Research, in collaboration with Evolution Research Group, was proud to support this multi-center, placebo-controlled, Phase 2b study across multiple U.S. … Read more

Lotus and ERG Partner with Concentric on Successful Vocacapsaicin Bunionectomy Pain Management Clinical Trial

by

Lotus and ERG Partner with Concentric on Successful Vocacapsaicin Bunionectomy Pain Management Clinical Trial The Lotus Team is thrilled to have collaborated with both ERG and Concentric on this important trial. We are proud to have played a part in helping advance a potential new treatment for pain management. Congratulations Concentric! Evolution Research Group would … Read more

South Rampart Pharma Doses First Patient in Phase 1 Multiple Ascending Dose Trial of SPR-001

by

South Rampart Pharma Doses First Patient in Phase I Multiple Ascending Dose Trial of SPR-001  – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics –  – Data expected in 3Q 2023 – NEW ORLEANS, Aug. 22, 2023 /PRNewswire/ … Read more

Pacira’s Exparel Shows Positive Results in Knee Arthroplasty Clinical Study

by

News & Press Pacira’s Exparel Shows Positive Results in Knee Arthroplasty Clinical Study Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in total knee arthroplasty (TKA), providing scientific consulting and conducting the study within our CRO and the ERG site network. ERG-Lotus was able enroll this study far more … Read more